Tianjin Zhongxin Pharmaceutical Group

Tianjin Zhongxin Pharmaceutical Group Corporation Limited is principally engaged in investment holding, production and sale of traditional Chinese medicine, western medicine and health products. On August 31, 2007, the Company terminated one of its subsidiaries, Tianjin Zhong Xin Fei Ying Pharmaceutical Co., Ltd. On December 10, 2007, it disposed 40% of its interest in Tianjin Zhong Xin Keju Biological Pharmaceutical Co., Ltd (Ke Ju) to a third party, thereby reducing its interest to 35%. The Company’s key products are Suxiao Jiuxin Wan, Huoxiang Zhengqi Ruan Jiaonang, Zilong Jin Pian, Jinqi Jiangtang Pian, Weichang An Wan, Biqi Jiaonang, a-2b Interferon, Gliclazide and Te Zi She Fu.